Top 25 Silverback Therapeutics investors
The most complete profiles first. Showing 25 of 25.
David BonitaVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 93 more
Verified email available
Geoffrey HsuVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Jon RootVerified
Venture Capital · United States
Health CareCybersecurityWomen FoundedEnterprise SoftwarePortfolio: Livefyre, Edgewise Therapeutics, HighLife, ZypMedia and 61 more
Verified email available
Jonathan SilversteinVerified
Private Equity Firm · United States
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Jonathan WangVerified
Private Equity Firm · China
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Oleg NodelmanVerified
Venture Capital, Private Equity Firm · United States
Health CareInvestment ManagementAndroidLife SciencePortfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more
Verified email available
Rick LewisVerified
Venture Capital · United States
Health CareCybersecurityWomen FoundedEnterprise SoftwarePortfolio: Livefyre, Edgewise Therapeutics, HighLife, ZypMedia and 61 more
Verified email available
Rishi GuptaVerified
Private Equity Firm · United States
Health CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Sarah MarriottVerified
Venture Capital, Private Equity Firm · United States
Health CareInvestment ManagementAndroidLife SciencePortfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more
Verified email available
Scott PlatshonVerified
Venture Capital, Private Equity Firm · United States
Health CareInvestment ManagementAndroidLife SciencePortfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more
Verified email available
Steve KrauszVerified
Venture Capital · United States
Health CareCybersecurityWomen FoundedEnterprise SoftwarePortfolio: Livefyre, Edgewise Therapeutics, HighLife, ZypMedia and 66 more
Verified email available
Carter Neild
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Chau Khuong
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Gennao Bio, Yisheng Biopharma and 89 more
Contact details available
Jacques Benkoski
Venture Capital, Strategy Operator, CEO · United States
Series AHealth CareCybersecurityWomen FoundedEnterprise SoftwarePortfolio: Livefyre, Edgewise Therapeutics, HighLife, ZypMedia and 64 more
Contact details available
Ran Nussbaum
Venture Capital, Founder, Private Equity Firm · Israel
Series BHealth CareLife ScienceInformation Technology (IT)ManufacturingPortfolio: Rewalk Robotics, VBI Vaccines, CathWorks, ProtAb and 48 more
Contact details available
Scotland Stevens
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Thomas Lips
Venture Capital, Private Equity Firm, Investor · Switzerland
SeedHealth CareWomen FoundedLife ScienceInformation Technology (IT)Portfolio: Black Diamond Therapeutics, Blueprint Medicines, TRACON Pharmaceuticals, Jounce Therapeutics and 30 more
Contact details available
ohad hammer
Venture Capital, Scout, Private Equity Firm · Israel
Series BHealth CareLife ScienceInformation Technology (IT)ManufacturingPortfolio: Rewalk Robotics, VBI Vaccines, CathWorks, ProtAb and 48 more
Contact details available
Anat Naschitz
Private Equity Firm · Israel
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Caroline Stout
Venture Capital, Private Equity Firm · United States
Health CareInvestment ManagementAndroidLife SciencePortfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more
Contact details available
Dafina Toncheva
Venture Capital · United States
Health CareCybersecurityWomen FoundedEnterprise SoftwarePortfolio: Livefyre, Edgewise Therapeutics, HighLife, ZypMedia and 64 more
Contact details available
Erez Chimovits
Private Equity Firm · Israel
Health CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Norman Zhou
Venture Capital · United States
Health CareWomen FoundedLife ScienceInformation Technology (IT)Portfolio: Black Diamond Therapeutics, AveXis, Aligos Therapeutics, Tyra Biosciences and 46 more
Contact details available
Sundeep AgrawalVerified
Private Equity Firm · United States
Health CareWellnessWomen FoundedLife SciencePortfolio: Ignyta, Silverback Therapeutics, Erasca, ReCode Therapeutics and 1 more
Verified email available
Darren Blanton
Private Equity Firm · United States
Health CareWellnessWomen FoundedLife SciencePortfolio: Ignyta, Silverback Therapeutics, Erasca, ReCode Therapeutics and 1 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Silverback Therapeutics investors are on Angel Roster?
Angel Roster lists 25 Silverback Therapeutics investors. 12 of them (48%) include a verified email address.
What types of investors are they?
The most common investor types are Private Equity Firms (19), Venture Capital Firms (18) and Operator Investors (1). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Silverback Therapeutics investors invest in?
Among those that list a stage, the most common are Seed (6), Series A (6) and Series B (2).
Where are Silverback Therapeutics investors based?
Most are based in the United States (19), Israel (4) and Switzerland (1).
Which companies have Silverback Therapeutics investors backed?
The most-backed portfolio companies among them are Scorpion Therapeutics (16), Cleave Therapeutics (16), Edgewise Therapeutics (15), Nuvation Bio (15) and Syros Pharmaceuticals (14).
How do I contact Silverback Therapeutics investors?
Create a free Angel Roster account to search and filter all 25, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.